MPN Hematology Academy 2024 Related VDO
Basic Sciences: Mutations Drive Poor Prognosis
19 min 35 sec
Basic Sciences: Mutations Drive Poor Prognosis
PONLAPAT ROJNUCKARIN, M.D.
KING CHULALONGKORN MEMORIAL HOSPITAL
Role of JAK-inhibitor & Practical Considerations to Maximize Overall Survival Benefits
20 min 18 sec
Role of JAK-inhibitor & Practical Considerations to Maximize Overall Survival Benefits
NOPPACHARN UAPRASERT, M.D.
KING CHULALONGKORN MEMORIAL HOSPITAL
Polycythemia Vera (PV) Taking the key factors that determine in high-risk PV
23 min 13 sec
Polycythemia Vera (PV) Taking the key factors that determine in high-risk PV
ARCHROB KHUHAPINANT, M.D.
SIRIRAJ HOSPITAL
Interactive Case Discussion | MPN Case 1: Clinical Insights into ET with HU Related Leg Ulcer
34 min 28 sec
Interactive Case Discussion | MPN Case 1: Clinical Insights into ET with HU Related Leg Ulcer
YINGYONG CHINTHAMMITR, M.D.
SIRIRAJ HOSPITAL
Interactive Case Discussion | MPN Case 2: Treating Early-Stage Myelofibrosis
20 min 04 sec
Interactive Case Discussion | MPN Case 2: Treating Early-Stage Myelofibrosis
THEERIN LANAMTIENG, M.D.
SRINAGARIND HOSPITAL
Interactive Case Discussion | MPN Case 3: Post-PV MF: Update on Prognosis & Treatment
22 min 47 sec
Interactive Case Discussion | MPN Case 3: Post-PV MF: Update on Prognosis & Treatment
RATTAPAN LAMOOL, M.D.
PHRAMONGKUTKLAO HOSPITAL
Interactive Case Discussion | MPN Case 4: Treatment approach in high-risk PV with HU resistance
22 min 56 sec
Interactive Case Discussion | MPN Case 4: Treatment approach in high-risk PV with HU resistance
TEERAYA PUAVILAI, M.D.
RAMATHIBODI HOSPITAL